180 related articles for article (PubMed ID: 28252813)
1. Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients.
Trattner H; Blüml S; Steiner I; Plut U; Radakovic S; Tanew A
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1681-1685. PubMed ID: 28252813
[TBL] [Abstract][Full Text] [Related]
2. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.
Sarıkaya Solak S; Kara Polat A; Kilic S; Oguz Topal I; Saricaoglu H; Karadag AS; Canpolat F; Kartal SP; Deveci BN; Kacar N; Polat Ekinci A; Guner R; Polat M; Dogan G; Guler Ozden M; Bulbul Baskan E; Ozaydin Yavuz G; Adisen E; Gulekon A; Tanribilir ME; Yilmaz O; Akman Karakas A; Ozturk P; Didar Balci D; Gonulal M; Yondem H; Turel Ermertcan A; Sendur N; Topyildiz H; Korkmaz S; Alpsoy E
Clin Exp Dermatol; 2022 Jan; 47(1):63-71. PubMed ID: 34236713
[TBL] [Abstract][Full Text] [Related]
4. Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
Benzian-Olsson N; Dand N; Chaloner C; Bata-Csorgo Z; Borroni R; Burden AD; Cooper HL; Cornelius V; Cro S; Dasandi T; Griffiths CEM; Kingo K; Koks S; Lachmann H; McAteer H; Meynell F; Mrowietz U; Parslew R; Patel P; Pink AE; Reynolds NJ; Tanew A; Torz K; Trattner H; Wahie S; Warren RB; Wright A; Barker JN; Navarini AA; Smith CH; Capon F;
JAMA Dermatol; 2020 Nov; 156(11):1216-1222. PubMed ID: 32936291
[TBL] [Abstract][Full Text] [Related]
5. Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.
Kim DH; Lee JY; Cho SI; Jo SJ
JAMA Dermatol; 2022 Jun; 158(6):650-660. PubMed ID: 35476054
[TBL] [Abstract][Full Text] [Related]
6. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
7. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).
Sanchez-Carazo JL; López-Estebaranz JL; Guisado C
J Dermatol; 2014 Aug; 41(8):673-8. PubMed ID: 24942203
[TBL] [Abstract][Full Text] [Related]
9. General Characteristics and Comorbidities in Patients with Palmoplantar Pustulosis.
Misiak-Galazka M; Wolska H; Galazka A; Kwiek B; Rudnicka L
Acta Dermatovenerol Croat; 2018 Jun; 26(2):109-118. PubMed ID: 29989866
[TBL] [Abstract][Full Text] [Related]
10. Pack-year cigarette smoking affects the course of palmoplantar pustulosis.
Putra-Szczepaniak M; Reich A; Jankowska-Konsur A; Czarnecka A; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
Adv Clin Exp Med; 2021 Feb; 30(2):189-195. PubMed ID: 33636060
[TBL] [Abstract][Full Text] [Related]
11. Severity and management of psoriasis within primary care.
Wade AG; Crawford GM; Young D; Leman J; Pumford N
BMC Fam Pract; 2016 Oct; 17(1):145. PubMed ID: 27737638
[TBL] [Abstract][Full Text] [Related]
12. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
14. A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in Spain.
Puig L; van de Kerkhof PCM; Reich K; Bachelez H; Barker J; Girolomoni G; Paul C
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1176-1182. PubMed ID: 28271561
[TBL] [Abstract][Full Text] [Related]
15. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
Phan C; Sigal ML; Lhafa M; Barthélémy H; Maccari F; Estève E; Reguiai Z; Perrot JL; Chaby G; Maillard H; Bégon E; Alexandre M; Toussaint P; Bastien-Jacquin M; Bravard P; Sauque E; de Quatrebarbes J; Pfister P; Beauchet A; Mahé E;
Ann Dermatol Venereol; 2016 Apr; 143(4):264-74. PubMed ID: 26969480
[TBL] [Abstract][Full Text] [Related]
16. Validation and usability of modified palmoplantar psoriasis area and severity index in patients with palmoplantar psoriasis: A prospective longitudinal cohort study.
Nagendran A; Hanumanthu V; Dogra S; Narang T; Venkata Maha Pinnaka L
Indian J Dermatol Venereol Leprol; 2023 May; ():1-8. PubMed ID: 37317722
[TBL] [Abstract][Full Text] [Related]
17. The skin in psoriasis: assessment and challenges.
Oji V; Luger TA
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S14-9. PubMed ID: 26472560
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.
Kubota K; Kamijima Y; Sato T; Ooba N; Koide D; Iizuka H; Nakagawa H
BMJ Open; 2015 Jan; 5(1):e006450. PubMed ID: 25588781
[TBL] [Abstract][Full Text] [Related]
19. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions.
Masuda-Kuroki K; Kawakami H; Abe N; Mori M; Tobita R; Fukushi R; Hiruma J; Takeda Y; Okubo Y
J Dermatol Sci; 2022 Apr; 106(1):29-36. PubMed ID: 35307234
[TBL] [Abstract][Full Text] [Related]
20. 308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
Niimura Y; Kamata M; Ishikawa T; Nagata M; Ito M; Watanabe A; Egawa S; Uchida H; Hiura A; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Tada Y
J Dermatol; 2024 Jul; 51(7):977-984. PubMed ID: 38483008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
